期刊文献+

比拉斯汀关键中间体的合成

Synthesis of Key Intermediates of Bilastine
下载PDF
导出
摘要 以2-[1-(4-溴苯基)-1-甲基乙基]-4,5-二氢-4,4-二甲基唑为原料,通过与二溴乙烷的格氏反应得到4-[1-(5,5-二氢-4,4-二甲基-2-唑基)-1-甲基乙基]-2-苯乙基溴,再与2-(4-哌啶基)-1H-苯并咪唑在碱性条件下经亲核取代得到比拉斯汀中间体2-(2-(4-(2-(4-(1H-苯并咪唑-2-基)哌啶-1-基)乙基)苯基)丙-2-基)-4,4-二甲基4,5-二氢唑,总收率63%。新工艺不仅避免了正丁基锂、环乙烷等危险试剂的使用,而且降低了安全隐患和环境污染,简化了实验步骤,且操作简便、收率高,适合工业化生产。 2-(2-(4-Bromophenyl) propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole was used as the starting material,2-(2-(4-(2-bromoethyl) phenyl) propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole was synthesized via Grignard reaction by reacted with 1,2-dibromoethane.The brominated product further reacted with 2-(piperidin-4-yl)-1 H-benzo imidazole in the presences of base to afford 2-(2-(4-(2-(4-(1 H-benzo imidazol-2-yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazoe the key intermediate of bilastine with an overall yield of 63%.The process avoids the use of fuming N-butyllithium,ethylene oxide and other dangerous reagents,reduces potential safety hazard and environmental pollution.Furthermore,this process also has some other advantages such as simple operation,high yield,and it is suitable for industrial production.
作者 韩在祺 王森 崔佰吉 冯波 姚璐 昌盛 HAN Zai-qi;WANG Sen;CUI Bai-ji;FENG Bo;YAO Lu;CHANG Sheng(Jilin Medical University,Jilin 132013,China)
机构地区 吉林医药学院
出处 《化学试剂》 CAS 北大核心 2018年第10期1005-1007,共3页 Chemical Reagents
基金 吉林医药学院大学生创新创业计划项目(2018) 吉林市科技创新发展计划项目(201750237)
关键词 比拉斯汀 关键中间体 合成 bilastine key intermediates synthesis
  • 相关文献

参考文献4

二级参考文献29

  • 1安杨,高丽,刘俊昌,包晓玲,刘江.乌鲁木齐市成年人变应性鼻炎流行病学调查[J].中国中西医结合耳鼻咽喉科杂志,2005,13(4):231-232. 被引量:46
  • 2万学峰,惠艳.H1抗组胺药物研究进展[J].国际皮肤性病学杂志,2006,32(3):147-149. 被引量:12
  • 3吴家昇,林其得,林晃,严道南.中医药治疗过敏性鼻炎进展[J].时珍国医国药,2006,17(5):832-833. 被引量:18
  • 4韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:402
  • 5Corc6stegui R, Labeaga L, Innerrity A, et al. Preclinical pharmacology of bilastine, a new selective histamine Hl receptor antagonist: receptor selectivity and in vitro anti- histaminic activity [J]. Drugs R D, 2005, 6 (6) : 371-384.
  • 6Carter NJ. Bilastine: in allergic rhinitis and urticaria [J]. Drugs, 2012, 72(9): 1257-1269.
  • 7Sadaba B, Azanza JR, Rodil R, et al. Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria [J]. Ther Clin RiskManag, 2013, 9: 197-205.
  • 8Orjales A, Rubio V, Bordell M. Benzimidazole derivatives with antihistaminic activity: EP, 0818454 [P]. 1998-01-14.
  • 9Orjales-Venero A, Rubio-Royo V. New piperidine derivatives of benzimidazole as antihistaminic and antiallergic agents: EP, 0580541 [P]. 1994-01-26.
  • 10Collier S J, Wu X, Poh Z, et al. Alternative synthesis of bilastine [J]. Synth Commun, 2011, 41 (9) : 1394-1402.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部